Two new biotechnology books: I’m proud to announce two new books featuring international best practices in biotechnology business development and […]
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Follow-on biologics are a foregone conclusion in the
Browsing around the Biotechnology Industry Organization site late last night, I was surprised to find that BIO’s press release section
Browsing around the Biotechnology Industry Organization site late last night, I was surprised to find that BIO’s press release section
I’ll be at Rutgers on February 29th, giving a talk on biotechnology entrepreneurship. My objective is to dispel the popular
The following appeal for generic biologic legislation was sent in from Insmed via youtube. I’ve posted previously on the challenges
Two new biotechnology books due out in March 2008: [AMAZONPRODUCT=0973467673] Best Practices in Biotechnology Education 22 International Best Practices in
On returning from a meeting with a small biotechnology firm in which I serve on the advisory board, I was
Want biotechnology venture capital? Use a shotgun! Read Post »
After months of work, the January issue of the Journal of Commercial Biotechnology, my first as managing editor, has just
Journal of Commercial Biotechnology – January 2008 Read Post »
My recent presentation at the “Biotechnology for Turkey” conference has been posted online. My central thesis was that the challenges
Get new actionable insights and updates from BiotechBlog
